MedTrace Logo

Analysis of Donor Biopsy Tissue Samples at the Time of Kidney Transplant

NCT01271465 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-11-26

No results posted yet for this study

Summary

The purpose of this study is to see if substances measured in a small piece of the donor organ predicts how well the organ will function in the recipient after transplant. We will be testing blood, urine, and biopsy tissue samples in this study. The research team will be looking at different risk factors in the donor organ that predict how well the kidney will do in the recipient.

Conditions

  • Kidney Transplantation

Interventions

PROCEDURE

Kidney Biopsy

biopsy of transplant kidney

Sponsors & Collaborators

  • Qatar National Research Fund

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Samuel Sultan, MD · Weill Cornell Medicine/Department of Surgery

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2021-09-18
Completion
2021-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01271465 on ClinicalTrials.gov